ABCL logo

AbCellera Biologics Inc. (ABCL) CAPEX

annual CAPEX:

$78.40M+$889.00K(+1.15%)
December 31, 2024

Summary

  • As of today (August 29, 2025), ABCL annual capital expenditures is $78.40 million, with the most recent change of +$889.00 thousand (+1.15%) on December 31, 2024.
  • During the last 3 years, ABCL annual CAPEX has risen by +$19.94 million (+34.12%).
  • ABCL annual CAPEX is now at all-time high.

Performance

ABCL CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

quarterly CAPEX:

$13.80M+$3.17M(+29.78%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL quarterly capital expenditures is $13.80 million, with the most recent change of +$3.17 million (+29.78%) on June 1, 2025.
  • Over the past year, ABCL quarterly CAPEX has dropped by -$5.99 million (-30.28%).
  • ABCL quarterly CAPEX is now -63.13% below its all-time high of $37.43 million, reached on June 30, 2021.

Performance

ABCL quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

TTM CAPEX:

$57.30M-$5.99M(-9.47%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL TTM capital expenditures is $57.30 million, with the most recent change of -$5.99 million (-9.47%) on June 1, 2025.
  • Over the past year, ABCL TTM CAPEX has dropped by -$21.11 million (-26.92%).
  • ABCL TTM CAPEX is now -33.34% below its all-time high of $85.96 million, reached on March 31, 2024.

Performance

ABCL TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

ABCL CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.1%-30.3%-26.9%
3 y3 years+34.1%-55.7%-8.6%
5 y5 years+1861.4%+272.8%+517.1%

ABCL CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.1%-55.7%+32.5%-33.3%at low
5 y5-yearat high+1861.4%-63.1%+686.5%-33.3%+517.1%
alltimeall timeat high+1861.4%-63.1%+686.5%-33.3%+926.4%

ABCL CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$13.80M(+29.8%)
$57.30M(-9.5%)
Mar 2025
-
$10.64M(-25.5%)
$63.30M(-17.6%)
Dec 2024
$78.40M(+1.1%)
$14.28M(-23.2%)
$76.80M(+1.1%)
Sep 2024
-
$18.58M(-6.1%)
$75.99M(-3.1%)
Jun 2024
-
$19.80M(-18.0%)
$78.41M(-8.8%)
Mar 2024
-
$24.14M(+79.3%)
$85.96M(+11.9%)
Dec 2023
$77.51M(+6.7%)
$13.46M(-35.9%)
$76.81M(+4.1%)
Sep 2023
-
$21.01M(-23.2%)
$73.76M(+11.1%)
Jun 2023
-
$27.35M(+82.5%)
$66.38M(-5.4%)
Mar 2023
-
$14.98M(+43.9%)
$70.16M(+0.7%)
Dec 2022
$72.66M
$10.41M(-23.6%)
$69.68M(+1.6%)
Sep 2022
-
$13.63M(-56.2%)
$68.59M(+9.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
$31.14M(+114.8%)
$62.69M(-9.1%)
Mar 2022
-
$14.49M(+55.4%)
$68.98M(+18.7%)
Dec 2021
$58.45M(+298.4%)
$9.33M(+20.7%)
$58.13M(+15.0%)
Sep 2021
-
$7.73M(-79.4%)
$50.56M(+7.5%)
Jun 2021
-
$37.43M(+927.2%)
$47.03M(+253.6%)
Mar 2021
-
$3.64M(+107.6%)
$13.30M(-12.7%)
Dec 2020
$14.67M(+267.1%)
$1.75M(-58.2%)
$15.24M(+13.0%)
Sep 2020
-
$4.20M(+13.4%)
$13.48M(+45.2%)
Jun 2020
-
$3.70M(-33.7%)
$9.29M(+66.3%)
Mar 2020
-
$5.58M
$5.58M
Dec 2019
$4.00M(-24.7%)
-
-
Dec 2018
$5.31M
-
-

FAQ

  • What is AbCellera Biologics Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual CAPEX year-on-year change?
  • What is AbCellera Biologics Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly CAPEX year-on-year change?
  • What is AbCellera Biologics Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM CAPEX year-on-year change?

What is AbCellera Biologics Inc. annual capital expenditures?

The current annual CAPEX of ABCL is $78.40M

What is the all time high annual CAPEX for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual capital expenditures is $78.40M

What is AbCellera Biologics Inc. annual CAPEX year-on-year change?

Over the past year, ABCL annual capital expenditures has changed by +$889.00K (+1.15%)

What is AbCellera Biologics Inc. quarterly capital expenditures?

The current quarterly CAPEX of ABCL is $13.80M

What is the all time high quarterly CAPEX for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly capital expenditures is $37.43M

What is AbCellera Biologics Inc. quarterly CAPEX year-on-year change?

Over the past year, ABCL quarterly capital expenditures has changed by -$5.99M (-30.28%)

What is AbCellera Biologics Inc. TTM capital expenditures?

The current TTM CAPEX of ABCL is $57.30M

What is the all time high TTM CAPEX for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM capital expenditures is $85.96M

What is AbCellera Biologics Inc. TTM CAPEX year-on-year change?

Over the past year, ABCL TTM capital expenditures has changed by -$21.11M (-26.92%)
On this page